MD Biosciences

12/09/2025

Advancing preclinical research requires models that reflect real-world diversity. Learn about case studies in our whitepaper that strengthen translational relevance.

📄https://hubs.la/Q03V5gGP0

11/19/2025

Final day at SfN! 🧠 We’ve had a great week connecting with the neuroscience community. If you’re still here, swing by booth 820 before the day ends.

11/18/2025

A highlight from yesterday at SFN: Dr. Shlomi Golan presented on a new neurodegenerative mouse model, co-authored with Dr Sigal Meilin, Dr. Avital Schauder, and Dr. Stephanie Oren. 🔬

11/17/2025

👋 Hello from SfN 2025! We’re presenting our work on Spinal Cord Injury right now. Come stop by PSTR164 (H4)!

11/13/2025

🔬 From discovery to IND-enabling studies, MD Biosciences delivers GLP-compliant histology, IHC, and toxicology services. Our expert pathologists and toxicologists ensure every study is accurate, reproducible, and ready for regulatory submission.

Learn more here: https://hubs.la/Q03SRY240

GLP studies for preclinical and non-clinical discovery.

11/05/2025

Excited to share that our Chief Scientific Officer, Dr. Sigal Meilin, will be presenting on “Spinal Cord Injury: Animal Models and Human Studies” at ! Come stop by to learn more about translational spinal cord injury research.

Schedule a time to meet with us at SfN here: https://hubs.la/Q03RFR_b0

10/27/2025

is just around the corner! We’re looking forward to connecting with fellow neuroscientists and showcasing our work. Visit us at booth #820 and let us know if you’ll be attending!

https://hubs.la/Q03Q2Wzj0

10/09/2025

Join us at the upcoming Boston Vendor Discovery Day on Tuesday, October 21! A great opportunity to connect with our team, discuss ongoing and future projects, and explore our scientific capabilities. Looking forward to seeing our fellow researchers and collaborators in the Boston community there.

Register here if you are interested in attending: https://hubs.la/Q03MJKyH0.

Join us at Scientist.com's R&D Vendor Discovery Day in Boston/Cambridge to connect with top vendors and explore new research opportunities!

09/16/2025

MD Biosciences is proud to have signed the Marseille Declaration, joining peers across pharma in committing to the highest standards of animal housing and use in research. This represents an important step in ensuring these standards are upheld both within organizations and through external partners.

Read more about the declaration here: https://hubs.la/Q03JwQLd0

MD Biosciences commits to high animal welfare standards by signing the Marseille Declaration, enhancing ethical practices in pharmaceutical research.

09/10/2025

Gait analysis is a powerful tool for evaluating peripheral nerve injuries and repair in translational pig models. Watch a clip from our recent webinar and access the full session here:

https://hubs.la/Q03Htjkq0

09/08/2025

We had the opportunity to present at NeuPSIG 2025, sharing our work on chemotherapy-induced peripheral neuropathy, neuroma characterization in minipigs, VEP/ERG monitoring in STZ models, and nerve interface procedures in rats. It was a great conference filled with valuable discussions and shared learning across the pain research community!

View all the posters we presented here: https://hubs.la/Q03HfWX00

09/04/2025

Our first day at NeuPSIG in Berlin! We presented on neuropathic pain research and had the chance to meet with others in the field.